JAC Advance Access originally published online on July 24, 2006
Journal of Antimicrobial Chemotherapy 2006 58(3):705-706; doi:10.1093/jac/dkl285
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author 2006. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org
Correspondence |
Dissemination of nim-class genes, encoding nitroimidazole resistance, among different species of Gram-negative anaerobic bacteria isolated in Athens, Greece
1 Department of Microbiology, Laikon General Hospital Athens, Greece 2 Department of Microbiology, Medical School, National and Kapodistrian University of Athens Greece
*Corresponding author. Dr Joseph Papaparaskevas, Lecturer, Department of Microbiology, Medical School, National and Kapodistrian University of Athens, Mikras Asias 75, 11527, Athens, Greece. Tel: +30-210-7462142; Fax: +30-210-7462143; Email: ipapapar@med.uoa.gr
Keywords: Resistance mechanisms , anaerobes , resistance epidemiology
| The first 10% of the full text of this article appears below. |
Sir,
Metronidazole remains the cornerstone for treatment of anaerobic infections1 and, despite its widespread use, isolation of resistant strains is uncommon.1,2 Nevertheless, enzymatic modification mediated by nim-class genes is a well-characterized resistance mechanism, and a total of seven different nim genes have been described.3,4
The aim of the present study was to investigate the prevalence and to identify the nim gene types among Gram-negative anaerobic clinical strains belonging to different species, isolated from hospitalized patients, in Athens, Greece.
Since 2003, Gram-negative anaerobic
Transparency declarations